FDAnews
www.fdanews.com/articles/74808-alcon-s-second-quarter-sales-increase-12-8-percent

ALCON'S SECOND QUARTER SALES INCREASE 12.8 PERCENT

July 29, 2005

Alcon, Inc. (NYSE:ACL) reported global sales of $1,172.0 million for the second quarter of 2005, an increase of 12.8 percent over global sales in the second quarter of 2004, or 10.1 percent excluding the impact of foreign exchange fluctuations. Net earnings for the second quarter of 2005 increased 34.5 percent to $325.0 million, or $1.04 per share on a diluted basis, compared to adjusted net earnings of $241.6 million or $0.78 per share for the second quarter of 2004. Adjusted net earnings for the second quarter of 2004 include non-GAAP adjustments reconciled in the table below. Reported net earnings for the second quarter of 2004 were $299.2 million, or $0.96 per share.

PharmaLive (http://www.medadnews.com/News/index.cfm?articleid=260047)